Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 10, 2017
Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib
Georgina V Long, Zeynep Eroglu, Jeffrey Infante, et al.
Journal for Immunotherapy of Cancer
|
March 8, 2024
Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors
Nikhil I Khushalani, Patrick A Ott, Robert L Ferris, et al.
Journal for Immunotherapy of Cancer
|
June 4, 2021
Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial
Robert L Ferris, William C Spanos, Rom Leidner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 21, 2026
MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition
Max Schlaak, Carolina Cimminiello, Jacopo Pigozzo, et al.
Melanoma Research
|
November 25, 2020
Safety and efficacy of combination nivolumab plus ipilimumab in patients with advanced melanoma: results from a North American expanded access program (CheckMate 218)
F Stephen Hodi, Paul B Chapman, Mario Sznol, et al.
Cancer Discovery
|
December 30, 2016
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
Valsamo Anagnostou, Kellie N Smith, Patrick M Forde, et al.
Nature Reviews. Clinical Oncology
|
August 29, 2013
The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma
Howard L Kaufman, John M Kirkwood, F Stephen Hodi, et al.
Journal for Immunotherapy of Cancer
|
June 1, 2018
An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0
Ryan J Sullivan, Michael B Atkins, John M Kirkwood, et al.
Cancer Cell
|
September 11, 2020
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma
Catherine S Grasso, Jennifer Tsoi, Mykola Onyshchenko, et al.
Cancer Cell
|
December 11, 2020
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma
Catherine S Grasso, Jennifer Tsoi, Mykola Onyshchenko, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 10, 2017
Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib
Georgina V Long, Zeynep Eroglu, Jeffrey Infante, et al.
Journal for Immunotherapy of Cancer
|
March 8, 2024
Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors
Nikhil I Khushalani, Patrick A Ott, Robert L Ferris, et al.
Journal for Immunotherapy of Cancer
|
June 4, 2021
Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial
Robert L Ferris, William C Spanos, Rom Leidner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 21, 2026
MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition
Max Schlaak, Carolina Cimminiello, Jacopo Pigozzo, et al.
Melanoma Research
|
November 25, 2020
Safety and efficacy of combination nivolumab plus ipilimumab in patients with advanced melanoma: results from a North American expanded access program (CheckMate 218)
F Stephen Hodi, Paul B Chapman, Mario Sznol, et al.
Cancer Discovery
|
December 30, 2016
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
Valsamo Anagnostou, Kellie N Smith, Patrick M Forde, et al.
Nature Reviews. Clinical Oncology
|
August 29, 2013
The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma
Howard L Kaufman, John M Kirkwood, F Stephen Hodi, et al.
Journal for Immunotherapy of Cancer
|
June 1, 2018
An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0
Ryan J Sullivan, Michael B Atkins, John M Kirkwood, et al.
Cancer Cell
|
September 11, 2020
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma
Catherine S Grasso, Jennifer Tsoi, Mykola Onyshchenko, et al.
Cancer Cell
|
December 11, 2020
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma
Catherine S Grasso, Jennifer Tsoi, Mykola Onyshchenko, et al.
Page
of 2